Immunobiology of Cardiac Allograft and Xenograft Transplantation

Mayer, 1990, Orthotopic heart transplantation for complex congenital heart disease, J Thorac Cardiovasc Surg, 99, 484, 10.1016/S0022-5223(19)36979-X Boucek, 1990, Cardiac transplantation in infancy: Donors and recipients. Loma Linda University Pediatric Heart Transplant Group, J Pediatr, 116, 171, 10.1016/S0022-3476(05)82870-7 Webber, 1994, Orthotopic heart transplantation in children with congenital heart disease, Ann Thorac Surg, 58, 1664, 10.1016/0003-4975(94)91655-1 Sigfusson, 1997, Long-term survivors of pediatric heart transplantation: A multicenter report of sixty-eight children who have survived longer than five years, J Pediatr, 130, 862, 10.1016/S0022-3476(97)70270-1 Hunt, 1991, Long-term results of cardiac transplantation, Ann Rev Med, 42, 437, 10.1146/annurev.me.42.020191.002253 Zinkernagel, 1974, Restriction of in vitro T cell-mediated cytotoxicity in lymphocytec choriomeningitis within a syngeneic or semiallogeneic system, Nature, 248, 701, 10.1038/248701a0 Bretscher, 1970, A theory of selfnonself discrimination, Science, 169, 1042, 10.1126/science.169.3950.1042 Lafferty, 1975, A new analysis of allogeneic interactions, Aust J Exp Biol Med Sci, 53, 27, 10.1038/icb.1975.3 Talmage, 1977, Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s), Proc Natl Acad Sci U S A, 74, 1610, 10.1073/pnas.74.10.4610 June, 1990, Role of the CD28 receptor in T-cell activation, Immunol Today, 11, 211, 10.1016/0167-5699(90)90085-N Chen, 1994, Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule, J Immunol, 152, 4929, 10.4049/jimmunol.152.10.4929 Schwartz, 1992, Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy, Cell, 71, 1065, 10.1016/S0092-8674(05)80055-8 Damle, 1992, Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes, J Immunol, 148, 1985, 10.4049/jimmunol.148.7.1985 Grewal, 1996, Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis, Science, 273, 1864, 10.1126/science.273.5283.1864 Watts, 1999, T cell co-stimulatory molecules other than CD28, Curr Opin Immunol, 11, 286, 10.1016/S0952-7915(99)80046-6 Lafferty, 1983, Immunobiology of tissue transplantation: A return to the passenger leukocyte concept, Ann Rev Immunol, 1, 143, 10.1146/annurev.iy.01.040183.001043 Larsen, 1996, Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways, Nature, 381, 434, 10.1038/381434a0 Mandelbrot, 1999, Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts, J Immunol, 163, 3753, 10.4049/jimmunol.163.7.3753 Szot, 2000, Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival, Transplantation, 69, 904, 10.1097/00007890-200003150-00040 Pietra, 2000, CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II, J Clin Invest, 106, 1003, 10.1172/JCI10467 Lafferty, 1969, Reactions of the graft-versus-host (GVH) type, Aust J Exp Biol Med Sci, 47, 17, 10.1038/icb.1969.3 McCune, 1988, The SLID-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function, Science, 241, 1632, 10.1126/science.2971269 Kawamura, 1992, Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor, Transplantation, 53, 659, 10.1097/00007890-199203000-00032 Rouleau, 1996, Antigen-specific cytotoxic T cells mediate human fetal pancreas allograft rejection in SLID-hu mice, J Immunol, 157, 5710, 10.4049/jimmunol.157.12.5710 Friedman, 1999, Human CD4+ T cells mediate rejection of porcine xenografts, J Immunol, 162, 5256, 10.4049/jimmunol.162.9.5256 Friedman, 1999, A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts, Diabetes, 48, 2340, 10.2337/diabetes.48.12.2340 Korngold, 1985, Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences, J Immunol, 135, 3004, 10.4049/jimmunol.135.5.3004 Shoskes, 1994, Indirect presentation of MHC antigens in transplantation, Immunol Today, 15, 32, 10.1016/0167-5699(94)90023-X Swain, 1983, T cell subsets and the recognition of MHC class, Immunol Rev, 74, 129, 10.1111/j.1600-065X.1983.tb01087.x Bennett, 1997, Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help, J Exp Med, 186, 65, 10.1084/jem.186.1.65 Brossart, 1997, Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines, Blood, 90, 1594, 10.1182/blood.V90.4.1594 Kurts, 1996, Constitutive class I-restricted exogenous presentation of self antigens in vivo, J Exp Med, 184, 923, 10.1084/jem.184.3.923 Kurts, 1997, CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity, J Exp Med, 186, 2057, 10.1084/jem.186.12.2057 Halloran, 1996, Molecular mechanisms of new immunosuppressants, Clin Transplant, 10, 118 Halloran, 1996, In vivo immunosuppressive mechanisms, J Heart Lung Transplant, 15, 959 Kenyon, 1999, Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD 154, Proc Natl Acad Sci U S A, 96, 8132, 10.1073/pnas.96.14.8132 Kirk, 1997, CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates, Proc Natl Acad Sci U S A, 94, 8789, 10.1073/pnas.94.16.8789 Elwood, 1998, Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade, Transplantation, 65, 1422, 10.1097/00007890-199806150-00002 Feng, 1999, Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig, Transplantation, 67, 1607, 10.1097/00007890-199906270-00016 Gordon, 1998, Prolonged survival of rat islet and skin xenografts in mice treated with donor splenocytes and anti-CD154 monoclonal antibody, Diabetes, 47, 1199, 10.2337/diab.47.8.1199 Lenschow, 1992, Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g, Science, 257, 789, 10.1126/science.1323143 Weber, 1997, CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice, Cell Transplant, 6, 505, 10.1016/S0963-6897(97)00045-6 Yin, 1995, CD4-positive suppressor cells block allotransplant rejection, J Immunol, 154, 6339, 10.4049/jimmunol.154.12.6339 Herbert, 1988, Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants, Transplantation, 46, 128S, 10.1097/00007890-198808001-00024 Shizuru, 1990, Induction of donor specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy, Transplantation, 50, 366, 10.1097/00007890-199009000-00002 Onodera, 1996, Induction of “infectious” tolerance to MHC-incompatible cardiac all, grafts in CD4 monoclonal antibodytreated sensitized rat recipients, J Immunol, 157, 1944, 10.4049/jimmunol.157.5.1944 Pearson, 1992, Induction of transplantation tolerance in adults using donor antigen and anti-CD4 monoclonal antibody, Transplantation, 54, 475, 10.1097/00007890-199209000-00018 Pearson, 1993, Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation, Transplant Proc, 25, 786 Orosz, 1996, Prevention of murine cardiac allograft rejection and gallium nitrate, Comparison with anti-CD4 monoclonal antibody. Transplantation, 61, 783 Krieger, 1996, CD4+ but not CD8+ cells are essential for allorejection, J Exp Med, 184, 2013, 10.1084/jem.184.5.2013 Chen, 1992, Tolerance in the mouse to major histocompatibility complex-mismatched heart allografts, and to rat heart xenografts, using monoclonal antibodies to CD4 and CD8, Eur J Immunol, 22, 805, 10.1002/eji.1830220326 Pietra, 1999, CD4 T cells acutely reject cardiac allografts via direct donor recognition, Transplant Proc, 31, 92, 10.1016/S0041-1345(98)01452-3 Sayegh, 1998, The role of Tcell costimulatory activation pathways in transplant rejection, N Engl J Med, 338, 1813, 10.1056/NEJM199806183382506 Wecker, 1994, CD4+ T cells, without CD8+ or B lymphocytes, can reject xenogeneic skin grafts, Xenotransplantation, 1, 8, 10.1111/j.1399-3089.1994.tb00045.x Gill, 1994, CD4+ T cells are both necessary and sufficient for islet xenograft rejection, Transplant Proc, 26, 1203 VanBuskirk, 1996, Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations, Transplantation, 62, 300, 10.1097/00007890-199607270-00026 Gill, 1993, T-cell-T-cell collaboration in allograft responses, Curr Opin Immunol, 5, 782, 10.1016/0952-7915(93)90137-H Auchincloss, 1993, The role of “indirect” recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice, Proc Natl Acad Sci U S A, 90, 3373, 10.1073/pnas.90.8.3373 Stepkowski, 1987, The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice, Transplantation, 44, 753, 10.1097/00007890-198712000-00006 VanBuskirk, 1996, Transfusion of polarized TH2-like cell populations into SLID mouse cardiac allograft recipients results in acute allograft rejection, Transplantation, 62, 229, 10.1097/00007890-199607270-00014 Fangmann, 1992, T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection, Eur J Immunol, 22, 1525, 10.1002/eji.1830220627 Benham, 1995, Indirect T cell allorecognition of donor antigens contributes to the rejection of vascularized kidney allografts, Transplantation, 59, 1028, 10.1097/00007890-199504150-00019 Chen, 1996, Mechanisms of indirect allorecognition in graft rejection, Class II MHC allope pt ide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo. Transplantation, 62, 705 Gould, 1999, Direct and indirect recognition: The role of MHC antigens in graft rejection, Immunol Today, 20, 77, 10.1016/S0167-5699(98)01394-2 Campos, 1995, Survival of MHC-deficient mouse heterotopic cardiac allografts, Transplantation, 59, 187, 10.1097/00007890-199501000-00006 Markees, 1998, Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4, J Clin Invest, 101, 2446, 10.1172/JCI2703 Hanabuchi, 1994, Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity, Proc Natl Acad Sci U S A, 91, 4930, 10.1073/pnas.91.11.4930 Kagi, 1994, Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity, Science, 265, 528, 10.1126/science.7518614 Ju, 1994, Participation of target Fas protein in apoptosis pathway induced by CD4+ Th 1 and CD8+ cytotoxic T cells, Proc Natl Acad Sci U S A, 91, 4185, 10.1073/pnas.91.10.4185 Stalder, 1994, Fas antigen is the major target molecule for CD4+ T cell-mediated cytotoxicity, J Immunol, 152, 1127, 10.4049/jimmunol.152.3.1127 Seino, 1996, Contribution of Fas ligand to cardiac allograft rejection, Intl Immunol, 8, 1347, 10.1093/intimm/8.9.1347 Larsen, 1995, Fas-mediated cytotoxicity. An immunoeffector or immunoregulatory pathway in T cell-mediated immune responses?, Transplantation, 60, 221, 10.1097/00007890-199508000-00002 Nickerson, 1997, Manipulation of cytokine networks in transplantation: False hope or realistic opportunity for tolerance?, Transplantation, 63, 489, 10.1097/00007890-199702270-00001 Tracey, 1993, Tumor necrosis factor, other cytokines and disease, Ann Rev Cell Biol, 9, 317, 10.1146/annurev.cb.09.110193.001533 Josien, 1998, Fas ligand, tumor necrosis factor-alpha expression, and apoptosis during allograft rejection and tolerance, Transplantation, 66, 887, 10.1097/00007890-199810150-00013 Imagawa, 1990, Anti-tumor necrosis factor antibody enhances allograft survival in rats, J Surg Res, 48, 345, 10.1016/0022-4804(90)90072-A Saleem, 1996, Acute rejection of vascularized heart allografts in the absence of IFNgamma, Transplantation, 62, 1908, 10.1097/00007890-199612270-00039 Weis, 1997, Cardiac allograft vasculopathy: A review, Circulation, 96, 2069, 10.1161/01.CIR.96.6.2069 Costanzo, 1998, Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database, J Heart Lung Transplant, 17, 744 Grattan, 1989, Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis, JAMA, 261, 3561, 10.1001/jama.1989.03420240075030 Billingham, 1992, Histopathology of graft coronary disease, J Heart Lung Transplant, 11, 538 Gao, 1988, Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findings, J Am Coll Cardiol, 12, 334, 10.1016/0735-1097(88)90402-0 Russell, 1997, Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: Lack of progression to sclerotic lesions in B cell-deficient mice, Transplantation, 64, 1531, 10.1097/00007890-199712150-00005 Vella, 1999, Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides, Transplantation, 67, 1523, 10.1097/00007890-199906270-00005 Forbes, 1994, Evidence that recipient CD8+ T cell depletion does not alter development of chronic vascular rejection in a rat heart allograft model, Transplantation, 57, 1238, 10.1097/00007890-199404270-00017 Koglin, 2000, Attenuated cardiac allograft vasculopathy in mice with targeted deletion of the transcription factor STAT4, Circulation, 101, 1034, 10.1161/01.CIR.101.9.1034 Nielsen, 1993, Evidence for a primarily humoral rejection mechanism in concordant xenogeneic heart transplantation. A sequential immunohistological study in a hamster-to-rat model, APMIS, 101, 587, 10.1111/j.1699-0463.1993.tb00151.x Fryer, 1995, Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets, Transplantation, 59, 171, 10.1097/00007890-199501270-00003 Rose, 1991, Histopathology of hyperacute rejection of the heart: Experimental and clinical observations in allografts and xenografts, J Heart Lung Transplant, 10, 223 Rose, 1993, Antibody-mediated rejection following cardiac transplantation, Transpl Rev, 7, 140, 10.1016/S0955-470X(05)80013-8 Kirk, 1993, Ex vivo characterization of human antiporcine hyperacute cardiac rejection, Transplantation, 56, 785, 10.1097/00007890-199310000-00003 Auchincloss, 1988, Xenogeneic transplantation: A review, Transplantation, 46, 120, 10.1097/00007890-198807000-00001 Calne, 1970, Organ transplantation between widely disparate species, Transplant Proc, 2, 550 Platt, 1991, The barrier to xenotransplantation, Transplantation, 52, 937, 10.1097/00007890-199112000-00001 Platt, 1998, Acute vascular rejection, Xenotransplantation, 5, 169, 10.1111/j.1399-3089.1998.tb00024.x Artrip, 1997, Cardiac xenotransplantation, Curr Opin Cardiol, 12, 172, 10.1097/00001573-199703000-00013 Byrne, 1997, Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage, Transplantation, 63, 149, 10.1097/00007890-199701150-00027 Auchincloss, 1990, Xenografting: A review, Transpl Rev, 4, 14, 10.1016/S0955-470X(11)80002-9 Leventhal, 1993, The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model, Transplantation, 56, 1, 10.1097/00007890-199307000-00001 Pascher, 1997, Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor, Transplantation, 64, 384, 10.1097/00007890-199708150-00002 Hamelmann, 1994, Immediate destruction of xenogeneic islets in a primate model, Transplantation, 58, 1109, 10.1097/00007890-199411000-00009 Alter, 1990, Cellular basis of the proliferative response of human T cells to mouse xenoantigens, J Exp Med, 171, 333, 10.1084/jem.171.1.333 Rocha, 1991, Peripheral selection of the T cell repertoire, Science, 251, 1225, 10.1126/science.1900951 Kalinke, 1990, Strong xenogeneic HLA response in transgenic mice after introducing an a3 domain into HLA B27, Nature, 348, 642, 10.1038/348642a0 Gustafsson, 1990, Structure of miniature swine class II DRB genes: Conservation of hypervariable amino acid residues between distantly related mammalian species, Proc Natl Acad Sci U S A, 87, 9798, 10.1073/pnas.87.24.9798 Collins, 1989, Species specificity of interleukin 2 binding to individual receptor components, Eur J Immunol, 19, 1517, 10.1002/eji.1830190828 Moses, 1992, Evidence that multiple defects in cellsurface molecule interactions across species differences are responsible for diminished xenogeneic T cell responses, Transplantation, 53, 203, 10.1097/00007890-199201000-00039 Vignali, 1992, Species-specific binding of CD4 to the b2 domain of major histocompatibility complex class II molecules, J Exp Med, 175, 925, 10.1084/jem.175.4.925 Woolnough, 1979, Cytotoxic and proliferative lymphocyte responses to allogeneic and xenogeneic antigens in vitro, Aust J Exp Biol Med Sci, 57, 467, 10.1038/icb.1979.48 von Hoegen, 1989, Equivalence of human and mouse CD4 in enhancing antigen responses by a mouse class II-restricted T cell hybridoma, J Exp Med, 170, 1879, 10.1084/jem.170.6.1879 Law, 1994, Human CD4 restores normal T cell development and function in mice deficient in murine CD4, J Exp Med, 179, 1233, 10.1084/jem.179.4.1233 Barzaga-Gilbert, 1992, Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice, J Exp Med, 175, 1707, 10.1084/jem.175.6.1707 Clayton, 1989, Identification of residues affecting class II versus HIV-1 gp120 binding, Nature, 339, 548, 10.1038/339548a0 Irwin, 1989, Species-restricted interactions between CD8 and the a3 domain of class I influence the magnitude of the xenogeneic response, J Exp Med, 170, 1091, 10.1084/jem.170.4.1091 Lucas, 1990, The human anti-murine xenogeneic cytotoxic response I. Dependence on responder antigen-presenting cells, J Immunol, 144, 4548, 10.4049/jimmunol.144.12.4548 Greenstein, 1986, The role of T cell accessory molecules in the generation of class II-specific xenogeneic cytolytic T cells, J Immunol, 136, 2358, 10.4049/jimmunol.136.7.2358 Guerder, 1994, Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor a leads to autoimmunity in transgenic mice, Proc Natl Acad Sci U S A, 91, 5138, 10.1073/pnas.91.11.5138 Coulombe, 1996, Tissue immunogenicity: The role of MHC antigen and the lymphocyte costimulator B7-1, J Immunol, 157, 4790, 10.4049/jimmunol.157.11.4790 Yi, 1999, CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway, Transplantation, 67, 435, 10.1097/00007890-199902150-00017 Loudovaris, 1996, CD4+ T cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T cells and B cells, Transplantation, 61, 1678, 10.1097/00007890-199606270-00003 Rollins, 1994, Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2, Transplantation, 57, 1709, 10.1097/00007890-199457120-00004 Yamada, 1995, Direct and indirect recognition of pig class II antigens by human T cells, Transplant Proc, 27, 258 Shishido, 1997, Recognition of porcine major histocompatibility complex class I antigens by human CD8+ cytolytic T cell clones, Transplantation, 64, 340, 10.1097/00007890-199707270-00028 Xu, 1999, Allele-specific and peptide-dependent recognition of swine leukocyte antigen class I by human cytotoxic T-cell clones, Transplantation, 68, 473, 10.1097/00007890-199908270-00005 Bravery, 1995, Direct recognition of SLA- and HLA-like class II antigens on porcine endothelium by human T cells results in T cell activation and release of interleukin-2, Transplantation, 60, 1024, 10.1097/00007890-199511150-00025 Kievits, 1988, Recognition of xeno-(HLA, SLA) major histocompatibility complex antigens by mouse cytotoxic T cells is not H-2 restricted: A study with transgenic mice, Proc Nail Acad Sci U S A, 86, 617, 10.1073/pnas.86.2.617 Simon, 1998, Cross-species interaction of porcine and human integrins with their respective ligands: Implications for xenogeneic tolerance induction, Transplantation, 66, 385, 10.1097/00007890-199808150-00017 Herrlinger, 1996, Human T-cell activation is mediate predominantly by direct recognition of porcine SLA and involves accessory molecule interaction of ICAM1/LFA 1 and CD2/LFA3, Transplant Proc, 28, 650 Mueller, 1997, Humanized porcine VCAMspecific monoclonal antibodies with chimeric IgG2/G4 constant regions block human leukocyte binding to porcine endothelial cells, Mol Immunol, 34, 441, 10.1016/S0161-5890(97)00042-4 Dorling, 1996, Significant primary indirect human T-cell anti-pig xenoresponses observed using immature porcine dendritic cells and SLA-class II-negative endothelial cells, Transplant Proc, 28, 654 Gill, 1995, Immunobiology of cellular transplantation, Cell Transplant, 4, 361, 10.1016/0963-6897(95)00019-T Hao, 1987, Role of the L3T4+ T cell in allograft rejection, J Immunol, 139, 4022, 10.4049/jimmunol.139.12.4022 Scully, 1994, Mechanisms in CD4 antibody-mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells, Eur J Immunol, 24, 2383, 10.1002/eji.1830241019 Shizuru, 1987, Islet allograft survival after a single course of treatment of recipient with antibody to L3T4, Science, 237, 278, 10.1126/science.2955518 Zelenika, 1998, Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: No requirement for CD8+ T cells or B cells, J Immunol, 161, 1868, 10.4049/jimmunol.161.4.1868 Auchincloss, 1990, Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent, Transplant Proc, 22, 1059 Kaufman, 1988, Use of anti-L3T4 and anti-Ia treatments for prolongation of xenogeneic islet transplants, Transplantation, 46, 210, 10.1097/00007890-198808000-00005 Krieger, 1997, Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice, J Autoimmunity, 10, 309, 10.1006/jaut.1997.0126 Lacy, 1989, Effect of transplantation site and aL3T4 treatment on survival of rat, hamster, and rabbit islet xenografts in mice, Transplantation, 47, 761, 10.1097/00007890-198905000-00002 Mandel, 1992, The survival of xeno-, allo- and isografts in NOD mice and xenografts in other strains, after immunosuppression with anti-CD4 monoclonal antibody, Diabet Nutr Metab, 5, 91 Pierson, 1989, Xenogeneic skin graft rejection is especially dependent on CD4+ T cells, J Exper Med, 170, 991, 10.1084/jem.170.3.991 Wilson, 1989, Role of CD4+ T-lymphocytes in rejection by mice of fetal pig proislet xenografts, Diabetes, 38, 217, 10.2337/diab.38.1.S217 Wolf, 1995, Donor antigen-presenting cell-independent rejection of islet xenografts, Transplantation, 60, 1164, 10.1097/00007890-199511270-00018 Bennett, 1998, Help for cytotoxic-T-cell responses is mediated by CD40 signalling, Nature, 393, 474, 10.1038/30996 Ridge, 1998, A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell, Nature, 393, 474, 10.1038/30989 Schoenberger, 1998, T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions, Nature, 393, 480, 10.1038/31002 Gill, 1992, The role of direct and indirect antigen presentation in the response to islet xenografts, Transplant Proc, 24, 642 Wang, 1991, The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice, Proc Natl Acad Sci U S A, 88, 527, 10.1073/pnas.88.2.527 Simeonovic, 1992, CD4+ Tcell depletion in mice facilitates induction of tolerance to pig proislet xenografts: A comparison of NOD and CBA/H recipient models, Diabet Nutr Metab, 5, 133 Desai, 1993, Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocytedeficient mice, Transplantation, 55, 718, 10.1097/00007890-199304000-00006 Desai, 1993, Pancreatic islet allograft and xenograft survival in CD8+ T-lymphocyte-deficient recipients, Transplant Proc, 25, 961 Gill, 1992, Rejection of pancreatic islet xenografts does not require CD8+ T-lymphocytes, Transplant Proc, 24, 2877 Markmann, 1992, Indefinite survival of MHC class Ideficient murine pancreatic islet allografts, Transplantation, 54, 1085, 10.1097/00007890-199212000-00025 Markmann, 1994, Genetically engineered grafts to study xenoimmunity: A role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts, Surgery, 116, 242 Coulombe, 1999, Tolerance to antigen-presenting celldepleted islet allografts is CD4 T cell dependent, J Immunol, 162, 2503, 10.4049/jimmunol.162.5.2503 Benda, 1996, Xenograft rejection of porcine islet-like cell clusters in immunoglobulin- or Fc-receptor g-deficient mice, Transplantation, 62, 1207, 10.1097/00007890-199611150-00003 Chitilian, 1998, The strength of cell-mediated xenograft rejection in the mouse is due to the CD4+ indirect response, Xenotransplantation, 5, 93, 10.1111/j.1399-3089.1998.tb00014.x Chu, 1997, Xenogeneic but not allogeneic pancreatic islet graft survival in recipients lacking humoral immunity and major histocompatibility complex class II antigens, Transplant Proc, 29, 901, 10.1016/S0041-1345(96)00227-8 Obatake, 1999, T cells are necessary and critical for xenograft rejection in new concordant cardiac xenotransplant model, Transplantation, 67, 1480, 10.1097/00007890-199906150-00016 Lin, 1999, Rejection of hamster cardiac xenografts by rat CD4+ or CD8+ T cells, Transplant Proc, 31, 959, 10.1016/S0041-1345(98)01856-9 Murphy, 1996, T cell recognition of xenoMHC peptides during concordant xenograft rejection, Transplantation, 61, 1133, 10.1097/00007890-199604270-00001 Wolf, 1993, Xenoreactive T-cell lines initiate pancreatic islet graft destruction in vivo, Transplant Proc, 25, 440 Mombaerts, 1992, RAG-1-deficient mice have no mature B and T lymphocytes, Cell, 68, 869, 10.1016/0092-8674(92)90030-G Karlsson-Parra, 1996, Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice, Transplantation, 61, 1313, 10.1097/00007890-199605150-00005 Arakawa, 1994, Prolongation of heart xenograft survival in the NK-deficient rat, Transplant Proc, 26, 1266 Candinas, 1996, T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection, Transplantation, 62, 1920, 10.1097/00007890-199612270-00042 Lin, 1999, Rejection of cardiac xenografts by CD4+ or CD8+ T cells, J Immunol, 162, 1206, 10.4049/jimmunol.162.2.1206 Lin, 1997, Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses, J Immunol, 158, 5658, 10.4049/jimmunol.158.12.5658 Lin, 1997, Rejection of cardiac xenografts by NK cells and macrophages, Transplant Proc, 29, 2354, 10.1016/S0041-1345(97)00399-0 Sobel, 1994, Poly I:C induction of a-interferon in the diabetes-prone BB and normal Wistar rats. Dose-response relationships, Diabetes, 43, 518, 10.2337/diab.43.4.518 Lanier, 1998, NK cell receptors, Ann Rev Immunol, 16, 359, 10.1146/annurev.immunol.16.1.359 Inverardi, 1997, Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues, Transplantation, 63, 1318, 10.1097/00007890-199705150-00021 Blakely, 1994, Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection, Transplantation, 58, 1059, 10.1097/00007890-199411270-00001 Deng, 1997, NK cells, macrophages, and humoral immune responses are dominant in primary nonfunction of islet grafts in the dog-to-rat xenotransplant model, Transplant Proc, 29, 2062, 10.1016/S0041-1345(97)00232-7 Itescu, 1996, Circulating human mononuclear cells exhibit augmented lysis of pig endothelium after activation with interleukin 2, Transplantation, 62, 1927, 10.1097/00007890-199612270-00043 Goodman, 1996, Direct activation of porcine endothelial cells by human natural killer cells, Transplantation, 61, 763, 10.1097/00007890-199603150-00016 Donnelly, 1997, Human natural killer cells account for non-MHC class I-restricted cytolysis of porcine cells, Cell Immunol, 175, 171, 10.1006/cimm.1996.1053 Kirk, 1993, The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness, Transplantation, 55, 924, 10.1097/00007890-199304000-00043 Seebach, 1997, HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells, J Immunol, 159, 3655, 10.4049/jimmunol.159.7.3655 Smyth, 1999, Accessory function for NK1.1 + natural killer cells producing interferon-gamma in xenospecific cytotoxic T lymphocyte differentiation, Transplantation, 68, 840, 10.1097/00007890-199909270-00017 Wells, 1999, Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance, Nat Med, 5, 1303, 10.1038/15260 Li, 2000, The role of T cell apoptosis in transplantation tolerance, Curr Opin Immunol, 12, 522, 10.1016/S0952-7915(00)00133-3 Qin, 1993, “Infectious” transplantation tolerance, Science, 259, 974, 10.1126/science.8094901 Takeuchi, 1992, Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance, Transplantation, 53, 1281, 10.1097/00007890-199206000-00023 Dallman, 1993, Cytokines and peripheral tolerance to alloantigen, Immunol Rev, 133, 5, 10.1111/j.1600-065X.1993.tb01507.x Lakkis, 1997, Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4, J Immunol, 158, 24432448, 10.4049/jimmunol.158.5.2443 Brent, 2000, Tolerance and its clinical significance, World J Surg, 24, 787, 10.1007/s002680010126 Streilein, 1987, Mechanisms of neonatal transplantation tolerance, Transplant Proc, 19, 82 Streilein, 1991, Neonatal tolerance of H-2 alloantigens. Procuring graft acceptance the “old-fashioned” way, Transplantation, 52, 1, 10.1097/00007890-199107000-00001 McCullagh, 1990, Curtailment of autoimmunity following parabiosis with a normal partner, Immunology, 71, 595 Mohler, 1987, Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin 2-producing, tolerogen-specific T lymphocytes, J Immunol, 139, 2211, 10.4049/jimmunol.139.7.2211 Billingham, 1956, Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance, Philos Trans R Soc Lond B Biol Sci, 239, 357, 10.1098/rstb.1956.0006 Ramseier, 1973, T cells in recognition of histocompatibility antigens, Nature, 246, 351, 10.1038/246351a0 Gruchalla, 1983, Analysis of neonatally induced tolerance of H-2 alloantigens III. Ease of abolition of tolerance of class I, but not class II, antigens with infusions of syngeneic immunocompetent cells, Transplantation, 36, 318, 10.1097/00007890-198309000-00017 Posselt, 1990, Induction of donor-specific unresponsiveness by intrathymic islet transplantation, Science, 249, 1293, 10.1126/science.2119056 Sayegh, 1994, Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy, Transplantation, 58, 125, 10.1097/00007890-199407270-00001 Chavin, 1993, Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donorspecific tolerance in a cardiac transplant model, J Immunol, 151, 7249, 10.4049/jimmunol.151.12.7249 Thomas, 1997, Preclinical studies of allograft tolerance in rhesus monkeys: A novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts, Transplantation, 64, 124, 10.1097/00007890-199707150-00022 Lehmann, 1997, Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells, Transplantation, 64, 1181, 10.1097/00007890-199710270-00017 Hall, 1998, AntiCD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4, J Immunol, 161, 5147, 10.4049/jimmunol.161.10.5147 Mottram, 1993, Tolerance induction with antiCD8 monoclonal antibodies in the mouse heart transplant model, Transplant Proc, 25, 2935 Howland, 2000, The roles of CD28 and CD40 ligand in T cell activation and tolerance, J Immunol, 164, 4465, 10.4049/jimmunol.164.9.4465 Niimi, 1998, The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo, J Immunol, 161, 5331, 10.4049/jimmunol.161.10.5331 Lazarovits, 1992, Inhibition of alloreactivity in vitro by monoclonal antibodies directed against restricted isoforms of the leukocytecommon antigen (CD45), Transplantation, 54, 724, 10.1097/00007890-199210000-00030 Basadonna, 1998, Antibody-mediated targeting of CD45 isoforms: A novel immunotherapeutic strategy, Proc Natl Acad Sci USA, 95, 3821, 10.1073/pnas.95.7.3821 Nicolls, 2000, Anti-LFA-1 therapy induces longterm islet allograft acceptance in the absence of IFN-gamma or IL-4, J Immunol, 164, 3627, 10.4049/jimmunol.164.7.3627 Isobe, 1997, Assessment of tolerance induction to cardiac allograft by anti-ICAM-1 and Anti-LFA-1 monoclonal antibodies, J Heart Lung Transplant, 16, 1149 Isobe, 1996, Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies, Transplant Proc, 28, 1045 Isobe, 1996, Acceptance of primary skin graft after treatment with anti-intercellular adhesion molecule-1 and anti-leukocyte function-associated antigen-1 monoclonal antibodies in mice, Transplantation, 62, 411, 10.1097/00007890-199608150-00019 Huet, 1989, CD44 contributes to T cell activation, J Immunol, 143, 798, 10.4049/jimmunol.143.3.798 Hourmant, 1994, Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation, Transplantation, 57, 204, 10.1097/00007890-199401001-00008 Orosz, 1996, Local cellular immunology of experimental transplant vascular sclerosis, Clin Transplant, 10, 100 Hao, 1992, Facilitation of specific tolerance induction in adult mice by RS-61443, Transplantation, 53, 590, 10.1097/00007890-199203000-00020 Li, 1998, Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment, Transplantation, 66, 1387, 10.1097/00007890-199811270-00021 Hall, 1985, Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells, J Exp Med, 162, 1683, 10.1084/jem.162.5.1683 Ildstad, 1984, Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts, Nature, 307, 168, 10.1038/307168a0 Deng, 1997, IL-10 and TGF-beta gene transfer to rodent islets: effect on xenogeneic islet graft survival in naive and B-cell-deficient mice, Transplant Proc, 29, 2207, 10.1016/S0041-1345(97)00299-6 Judge, 1998, Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival, Transplantation, 66, 426, 10.1097/00007890-199808270-00003 Gainer, 1997, Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival, Transplantation, 63, 1017, 10.1097/00007890-199704150-00019 Dallman, 1987, Specific cytotoxic T cells are found in the nonrejected kidneys of blood-transfused rats, J Exp Med, 165, 566, 10.1084/jem.165.2.566 Miller, 1990, Tissuespecific expression of allogeneic class II MHC molecules induces neither tissue rejection nor clonal inactivation of alloreactive T cells, J Immunol, 144, 334, 10.4049/jimmunol.144.1.334 Wekerle, 1998, Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance, J Exp Med, 187, 2037, 10.1084/jem.187.12.2037 Parker, 1995, Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and anti-body to CD40 ligand, Proc Natl Acad Sci U S A, 92, 9560, 10.1073/pnas.92.21.9560 VanBuskirk, 2000, Human allograft acceptance is associated with immune regulation, J Clin Invest, 106, 145155, 10.1172/JCI9171 Kavelaars, 1996, Ontogency of the responses of human peripheral blood T cells to glucocorticoids, Brain Behavior Immun, 10, 288, 10.1006/brbi.1996.0025 Goldblatt, 1998, Immunisation and the maturation of infant immune responses, Dev Biol Stand, 95, 125 Schelonka, 1998, Neonatal immunology, Semin Perinatol, 22, 2, 10.1016/S0146-0005(98)80003-7 Vigano, 1999, Differential development of type 1 and type 2 cytokines and beta-chemokines in the ontogeny of healthy newborns, Biol Neonate, 75, 1, 10.1159/000014071 Schelonka, 1998, T cell receptor repertoire diversity and clonal expansion in human neonates, Pediatr Res, 43, 396, 10.1203/00006450-199803000-00015 Neubert, 1998, Evaluation of the age-dependent development of lymphocyte surface receptors in children, Life Sci, 62, 1099, 10.1016/S0024-3205(98)00033-2 Phocas, 1998, Soluble intercellular adhesion molecule-1 in newborn infants, Eur J Pediatr, 157, 153, 10.1007/s004310050788 Mosmann, 1991, Diversity of cytokine synthesis and function of mouse CD4+ T cells, Immunol Rev, 123, 209, 10.1111/j.1600-065X.1991.tb00612.x Delespesse, 1998, Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors, Vaccine, 16, 1415, 10.1016/S0264-410X(98)00101-7 Lilic, 1997, Cytokine production differs in children and adults, Pediatr Res, 42, 237, 10.1203/00006450-199708000-00018 Wells, 1998, Neonatal thymectomy: Does it affect immune function?, J Thorac Cardiovasc Surg, 115, 1041, 10.1016/S0022-5223(98)70403-9 Yamada, 1999, The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model, Transplantation, 68, 485, 10.1097/00007890-199908270-00007